e13577 Background: Patients with hematologic malignancies require intensive supportive care, including frequent lab monitoring and transfusion support. Home phlebotomy has been shown to improve patient satisfaction and reduce healthcare utilization; however, current standards of care typically exclude type-and-screen (T transfusion-dependent hematologic malignancy diagnosis; enrolled in T absence of at least 1 home T N = 14). The cohort was 36% male (5) and 64% female (9), age ranged from 28 – 86 years (median age = 68) and had 4 primary hematologic diseases: AML (10), ALL (2), MDS (1), and aplastic anemia (1). 201 of 212 (94.8%) T p = 0.001). Regarding adverse events, there were 7 total transfusion reactions, of which none were serologic. 4 reactions occurred in patients who had home T&Ss. Conclusions: This retrospective pilot study demonstrates the feasibility of integrating T&S testing into home phlebotomy. Collection of T&S at home was associated with shorter transfusion visit wait times, demonstrating increased care efficiency, which may positively impact patient quality of life. Interdisciplinary care coordination is needed for patient selection, handling/delivery of lab supplies, and visit scheduling. Future research should explore patients’ experiences with home T&S testing.
Marion et al. (Thu,) studied this question.